Neurolutions news
Neurolutions CSO and Founder Dr. Eric Leuthardt has contributed to two recently published studies showing proof that brain-computer interface therapy with the IpsiHand benefits the brain`s motor networks and also motor recovery in chronic stroke patients with extended usage.
The Food And Drug Administration has authorized a device called
IpsiHand robotic hand-piece uniquely leverages brain-computer interface technology for chronic stroke rehabilitation
Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, announced today that the U.S. Food and Drug Administration
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability
Dr. Eric Leuthardt has spent a lot of time imagining the future and in all the possible future scenarios depicted in science fiction, "where were the neural prosthetics?", he asks.